Serial #99712895
LIVE

Serial Number

99712895

Owner

DBV TECHNOLOGIES

Attorney

Anthony E. Bennett

Filing Date

Mar 19, 2026

Add to watchlist:

No watchlists yet
View on USPTO

Serial #99712895 Trademark

Serial Number: 99712895

Serial #99712895 is a trademark filed by DBV TECHNOLOGIES on March 19, 2026. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 16 (Paper Goods), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

DBV TECHNOLOGIES (42 trademarks)

177-181 avenue Pierre Brossolette
Montrouge 92120 , FR

Entity Type: 99

Trademark Details

Filing Date

March 19, 2026

Registration Date

Not Registered

Goods & Services

Training services for consumers and medical professionals in the field of allergies and immunotherapy; Provision of classes, seminars, educational programs, educational conferences, congresses, and workshops in the field of allergies and immunotherapy; Organizing and providing exhibitions for online educational purposes featuring interactive presentations and exhibitions in the field of allergies and immunotherapy; Publication of periodicals, books, and catalogs in the fields of allergies and immunotherapy; information, advisory and consultancy services relating to all of the aforesaid

Medical and scientific research in the fields of allergies and immunotherapy; Development services of scientific methods for cutaneous and epicutaneous immunotherapy; Medical and scientific research relating to the treatment, alleviation and prevention of autoimmune, infectious and inflammatory diseases; Medical and scientific research in the fields of allergy treatment and care; Allergenic drug discovery services; Medical and scientific research services, namely, developing methods for treating allergies via contact between allergens and the skin; Medical and scientific research services, namely, developing methods for the treatment and prevention of allergies, autoimmune, infectious and inflammatory diseases by applying patches to patients' skin; information, advisory and consultancy services relating to all of the aforesaid

Printed publications, namely, magazines in the field of immunotherapy; Printed posters; Printed pamphlets in the field of immunotherapy; Printed informational flyers and leaflets featuring information regarding immunotherapy; Printed newspapers; Printed matter in the nature of manual handbooks in the field of immunotherapy; Printed booklets in the field of immunotherapy; Printed magazines and journals featuring information about immunotherapy; Printed instructional and teaching material in the field of immunotherapy

Advertising and marketing services; Providing consumer product information regarding medical products to patients and healthcare professionals; Advertising and marketing services featuring medical goods, medical testing and diagnostic products and services; Market research; Business strategy development services; Business planning; Business data analysis; Business management; Business organization consulting; Business administration; Retail store services, online retail store services, and wholesale store services featuring transdermal patches, skin patches and adhesive skin patches for medical use, transdermal and adhesive skin patches for treating, alleviating and preventing the development and progression of allergies and immunological disorders, transdermal and adhesive skin patches for the transdermal delivery of pharmaceuticals and medical preparations, patches and epicutaneous systems for the cutaneous and epicutaneous administration of medical and pharmaceutical substances for treating allergies and immunological disorders, adhesive patches and adhesive epicutaneous systems for cutaneous and epicutaneous administration of medical and pharmaceutical substances for treating allergies and immunological disorders, occlusive patches and occlusive epicutaneous systems for cutaneous and epicutaneous administration of powdered medical and pharmaceutical substances for treating allergies and immunological disorders, patches and epicutaneous systems containing a powdered preparation for medical and pharmaceutical use for treating allergies and immunological disorders, patches and epicutaneous systems for use in the treatment of allergies and immunological disorders, patches and epicutaneous systems featuring allergens and antigens for treating allergies and immunological disorders, allergy medication, pharmaceutical preparations for treating allergies, pharmaceutical preparations for treating food allergies; Retail store services, online retail store services and wholesale store services connected with the sale of medical instruments, apparatus and devices for the cutaneous, epicutaneous and patch-based administration and delivery of medical and pharmaceutical substances for the treatment, alleviation and prevention of allergies and immunological disorders, pads and skin patches for receiving, holding and containing medical and pharmaceutical substances for the treatment, alleviation and prevention of allergies and immunological disorders, pads and skin patches for medical training purposes, pads and skin patches for medical use, namely, for use in training medical professionals on the transdermal delivery of pharmaceuticals and medical preparations, medical instruments, apparatus and devices sold without medication for the later administration, by cutaneous and epicutaneous means, of medical and pharmaceutical substances, pad, skin patch and occlusion patch dispensers and applicators for medical use; advisory, information and consultancy services relating to all of the aforesaid

Medical services relating to the treatment, alleviation and prevention of allergies; medical treatment, alleviation and prevention of allergies, inflammatory, autoimmune and infectious diseases through the administration of medical and pharmaceutical substances, allergens and antigens using patches affixed to patients' skin; medical consultancy in the field of desensitization to allergies; providing medical information regarding medical conditions, allergies, intolerances, treatments and products to patients and healthcare professionals; provision of medical advice to patients and healthcare professionals regarding medical conditions, allergies, intolerances and treatment; providing medical information regarding medical products to patients and healthcare professionals; information, advisory and consultancy services relating to all of the aforesaid

Filing History

TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 31, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 31, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 31, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 8, 2026 GNRN
NON-FINAL ACTION E-MAILED
Jun 8, 2026 GNRT
NON-FINAL ACTION WRITTEN
Jun 8, 2026 CNRT
ASSIGNED TO EXAMINER
May 26, 2026 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
May 18, 2026 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 18, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Mar 19, 2026 MAFR
NEW APPLICATION ENTERED
Mar 19, 2026 NWAP